Drug Shortage Report for TARO-ZOLEDRONIC ACID

Last updated on 2018-08-03 History
Report ID 177
Drug Identification Number 02415100
Brand name TARO-ZOLEDRONIC ACID
Common or Proper name ZOLEDRONIC ACID
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100 mL
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-11-01
Estimated end date 2018-07-31
Actual end date 2018-08-02
Shortage status Resolved
Updated date 2018-08-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2018-08-03 French Compare
v25 2018-08-03 English Compare
v24 2018-05-25 French Compare
v23 2018-05-25 English Compare
v22 2018-04-13 French Compare
v21 2018-04-13 English Compare
v20 2018-03-16 French Compare
v19 2018-03-16 English Compare
v18 2018-02-02 French Compare
v17 2018-02-02 English Compare
v16 2017-12-25 French Compare
v15 2017-12-25 English Compare
v14 2017-12-04 French Compare
v13 2017-12-04 English Compare
v12 2017-11-03 French Compare
v11 2017-11-03 English Compare
v10 2017-10-02 French Compare
v9 2017-10-02 English Compare
v8 2017-08-02 French Compare
v7 2017-08-02 English Compare

Showing 1 to 20 of 26